Rituximab induced cytokine release syndrome in an MS patient: A case report.
| Autor: | Etemadifar M; Department of Neurosurgery Alzahra University Hospital Isfahan University of Medical Sciences Isfahan Iran., Salari M; Functional Neurosurgery Research Center Shohada Tajrish Comprehensive Neurosurgical Center of Excellence Shahid Beheshti University of Medical Sciences Tehran Iran., Saeri M; Alzahra Research Institute Alzahra University Hospital Isfahan University of Medical Sciences Isfahan Iran., Sigari AA; Alzahra Research Institute Alzahra University Hospital Isfahan University of Medical Sciences Isfahan Iran., Ebrahimi Pelarti S; Alzahra Research Institute Alzahra University Hospital Isfahan University of Medical Sciences Isfahan Iran. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical case reports [Clin Case Rep] 2021 Jul 09; Vol. 9 (7), pp. e04407. Date of Electronic Publication: 2021 Jul 09 (Print Publication: 2021). |
| DOI: | 10.1002/ccr3.4407 |
| Abstrakt: | Cytokine release syndrome with rituximab has been reported in certain diseases, however, it is rarely reported in MS patients treated with rituximab. The treating physician should suspect the syndrome when typical signs and symptoms appear. Competing Interests: The authors have no competing interests to declare. (© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|